Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,837 | 5,047 | 3,573 | 1,562 | 1,213 |
| Other Working Capital | 64 | -81 | -21 | 135 | -155 |
| Other Operating Activity | -6,513 | -5,490 | -3,876 | -2,566 | -1,857 |
| Operating Cash Flow | $-613 | $-524 | $-324 | $-869 | $-799 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | 0 | 0 | 0 | -138,000 | -138,000 |
| Investing Cash Flow | $0 | $0 | $0 | $-138,000 | $-138,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 160 | 160 | 0 | 31 | 31 |
| Common Stock Issued | 0 | 0 | 0 | 140,075 | 140,075 |
| Other Financing Activity | -1 | -1 | 0 | -954 | -803 |
| Financing Cash Flow | $159 | $159 | $0 | $139,152 | $139,304 |
| Beginning Cash Position | 458 | 458 | 458 | 175 | 175 |
| End Cash Position | 5 | 93 | 135 | 458 | 680 |
| Net Cash Flow | $-454 | $-365 | $-324 | $283 | $505 |
| Free Cash Flow | |||||
| Operating Cash Flow | -613 | -524 | -324 | -869 | -799 |
| Free Cash Flow | -613 | -524 | -324 | -869 | -799 |